Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Strong dollar takes bite out of Novartis sales

Share this article

Strong dollar takes bite out of Novartis sales
The headquarters of Swiss pharmaceutical giant Novartis in Basel. Photo: AFP
13:08 CEST+02:00
Swiss pharmaceutical giant Novartis reported $4.1 billion (€3.8 billion) in income for the first half of the year, down 20 percent, due largely to a stronger dollar.

The Basel-based firm said its net sales over the last six months had fallen six percent to $24.6 billion, but grew four percent in local currencies.

Novartis, the world's largest pharmaceutical company in tems of sales, said in a statement that its outlook for its core business remained unchanged, with 2015 sales expected to grow in the mid-single digits.

The Swiss firm in March agreed to a massive asset swap with Britain's GlaxoSmithKline, and said Tuesday that implementation of the deal remains on track.

Under the deal GSK acquired Novartis's global human vaccines business while the two firms tied up their global consumer health operation under GSK control.

In return, GSK sold its oncology business to Novartis for $16 billion.

Earlier this month, US authorities launched a court action seeking $3.3 billion in fines from Novartis, on allegations it paid kickbacks to boost drug sales.

The filing notes that Novartis maintains it offered legal rebates to pharmacies it worked with.

"We are committed to creating a culture of integrity at Novartis and demonstrating ethical leadership, and have taken concrete steps to increase transparency and strengthen our ethical business practices," the Swiss firm said on Tuesday.

Get notified about breaking news on The Local

Share this article

Advertisement

From our sponsors

The Swedish university where students tackle real-world problems

Ranked among the world's best young universities in the QS Top 50 Under 50, Linköping University (LiU) uses innovative learning techniques that prepare its students to tackle the challenges of tomorrow.

Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement